Strongyloidiasis in Ethiopia: systematic review on risk factors, diagnosis, prevalence and clinical outcomes by Terefe, Yitagele et al.
SCOPING REVIEW Open Access
Strongyloidiasis in Ethiopia: systematic
review on risk factors, diagnosis, prevalence
and clinical outcomes
Yitagele Terefe1,2, Kirstin Ross3 and Harriet Whiley3*
Abstract
Background: Strongyloidiasis is a gastrointestinal infection caused by the parasitic nematode Strongyloides
stercoralis. It is estimated to infect up to 370 million people globally and is predominately found in tropical and
subtropical areas of socioeconomic disadvantage.
Main body: This systematic literature review identified studies published in the last ten years on the risk factors,
diagnosis, prevalence and/or clinical outcomes of strongyloidiasis in Ethiopia. The prevalence of S. stercoralis ranged
from 0.2 to 11.1% in adults, 0.3% to 20.7% in children, 1.5% to 17.3% in HIV positive adults and 5% in HIV positive
children. The identified studies primarily used microscopy based techniques that potentially underestimated the
prevalence four fold compared with serology and PCR. Strongyloidiasis in children presents a particularly significant
issue in Ethiopia as children often presented with anemia, which is associated with impaired mental and cognitive
development. The most significant risk factor for strongyloidiasis was HIV status and although other risk factors
were identified for helminth infections, none were statistically significant for S. stercoralis specifically. Several studies
detected S. stercoralis in dogs and non-biting cyclorrhaphan flies. However, future research is needed to explore the
role of these reservoirs in disease transmission.
Conclusions: This review demonstrated that strongyloidiasis is an overlooked and neglected disease in Ethiopia.
There is a need for a systematic approach using a combination of molecular and serology based diagnostic
methods to ascertain the true incidence and burden of strongyloidiasis in Ethiopia. Further research is also needed
to break the cycle of transmission by identifying environmental reservoirs, risk factors and exploring the potential
for zoonotic transfer.
Keywords: Neglected tropical disease, Soil transmitted helminth, Public health, Strongyloides stercoralis, AIDS, HIV,
Anemia
Multilingual abstracts
Please see Additional file 1 for translations of the
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Background
Strongyloidiasis is caused by infection with the parasitic
nematode worm, Strongyloides stercoralis, S. fuelleborni
or S. fuelleborni kelli [1, 2]. Symptoms of infection range
from asymptotic to non-specific gastrointestinal complaints
[2, 3] and distinctive form of cutaneous larva migrans, larva
currens [4]. The infection can remain undetected and un-
diagnosed for many decades [5, 6]. However, when an in-
fected person undergoes steroidal or immunosuppressive
treatment, the worm infection undergoes hyperinfection,
leading to enormous numbers of the parasite, which can
then disseminate and move to other organs, a condition
that is almost always fatal [7].
Strongyloidiasis has been assumed to be a disease as-
sociated with tropical or subtropical regions, and is
recognised as a neglected tropical disease. However, it
has been argued that strongyloidiasis should be de-
scribed as a disease of disadvantage, as it is primarily a
disease from developing countries and from poorer areas
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within developed countries [8]. Estimates of infection
rates globally range from 50–100 million [3, 4] to more
than 300 million [9]. The lower estimate is likely to be
an underestimate as the disease is often undiagnosed,
either because it is not looked for [3, 10] or because of
difficulties with diagnosis [2, 11].
Ethiopia’s economy is one of the fastest growing in the
world [12] although it is also one of the poorest countries
in Africa [13]. The Ethiopian health care sector is cur-
rently underfunded by both global and regional standards
[14] and housing and other environmental health hard-
ware components in many areas is substandard in both
rural and urban areas [15, 16]. The lack of health care and
poor environmental health conditions combine to make
the country susceptible to parasitic infections, including
strongyloidiasis. Here we evaluate the prevalence, risk fac-
tors and clinical outcomes for strongyloidiasis in Ethiopia
reported in the literature using a systematic approach.
Main text
Materials and methods
Search strategy
The databases Scopus (n = 46) and Web of Science (n =
44) were searched for articles written in English over the
last ten years containing the keywords Strongyloides OR
strongyloidiasis OR S. stercoralis OR S. fuelleborni AND
Ethiopia OR Ethiopian. Figure 1 presents the systematic
approach to article inclusion or exclusion. Articles were
screened by reading titles and abstracts and initially ex-
cluded if they did not refer to specifically to S. stercoralis
or if they were review articles. Article were further
screened by reading abstracts and full articles and ex-
cluded if they did not investigate the prevalence of
strongyloidiasis, or describe clinical presentations or po-
tential environmental sources. As the aim of this system-
atic review was to provide an overview of the state of
knowledge relating to strongyloidiasis in Ethiopia, all ar-
ticles which met the inclusion criteria were included re-
gardless of any flaw in study design. Limitations or bias
identified are discussed in the discussion section.
Results
Prevalence
A total of 40 publications published in the last 10 years
were identified that investigated the prevalence of stron-
gyloidiasis, described clinical presentations or potential
environmental sources. Table 1 presents the 27 publica-
tions that examined the prevalence of strongyloidiasis in
Fig. 1 Overview of search methods and articles inclusion and exclusion criteria
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different Ethiopian populations. In HIV negative adults
the prevalence of strongyloidiasis ranged from 0.2% to
11.1%. Combining the results from the 16 studies investi-
gating HIV negative adults demonstrated that the overall
prevalence was 0.5% (195 positive individuals out of 36
549 tested). However, this value is skewed by the large
samples size (32 191 people) and low incidence observed
in the study by Ramos et al [33]. This study did not inves-
tigate the general population but rather patients from
Gambo Rural Hospital presenting with diarrhea. The
omission of this study increased the overall prevalence in
healthy adults to 2.5%. It is also important to note that in
all of these studies investigating HIV negative adults,
Strongyloides was detected using microscopy based stool
examination techniques, which is likely to significantly
underestimate the prevalence due to false negative results.
In HIV negative children the prevalence of stron-
gyloidiasis ranged from 0.3% to 20.7% and the over-
all combined prevalence from 8 studies was 8.6%
(298 positive out of 3453 children). However, there
were significant variations in incidence depending on
the diagnostic technique used. The overall preva-
lence in children using microscopy based stool
examination techniques was 4% (from seven studies,
two of which concurrently used PCR or serology)
(Table 1); whereas the overall prevalence using PCR
detection from stools or serology was 17.5% (three
studies, two of which concurrently used microscopy).
The two studies which tested using more than one
detection method found 5% prevalence using micros-
copy compared with 17% using serology [19], and
4% using microscopy compared to 13% using PCR
[26]. This suggests that microscopy based techniques
could potentially underestimate prevalence by up to
four fold compared with serology or PCR. This is
consistent with the findings of Van Kesteren and
Wojciechowski [19] that concurrently tested faeces
using microscopy examination of stools and serology
and found positives in 4.8% and 16.5% of patients
respectively. Another study by Amor et al. reported
detection of 3.5% by stool, 12.1% by Baermann and
13.4% by PCR [26]. The most common diagnostic
technique by far was stool examination using the
formalin-ether concentration technique, followed by
the wet mount, Kato-Katz and Baermann with only
one or two studies each using saline smear mount,
sedimentation, agar, PCR or serology (Table 1).
The highest prevalence seen using microscopy based
stool examination was in HIV positive adults. The preva-
lence ranged from 1.5% to 17.3% and the overall com-
bined prevalence was 11%. There was only one study of
pediatric HIV patients which found the incidence to be
5% (2.5% in highly active antiretroviral therapy [HARRT]
initiated and 6.9% in HARRT naïve patients) [31].
Risk factors
The most significant risk factor for strongyloidiasis iden-
tified was HIV status (Table 1). Four studies compared
the prevalence of strongyloidiasis in HIV positive and
HIV negative individuals and the incidence was 5–20
times higher in HIV positive individuals compared with
HIV negative [20, 41, 43, 45].
Two studies reported that the prevalence of strongyl-
oidiasis in otherwise healthy individuals was slightly
higher in males compared to females [17, 18, 33] and
that higher incidence was seen in rural areas compared
with urban areas [34] and in farmers [17, 18]. Three
studies investigated food handlers; however, the overall
prevalence was 2.7%, which is not significantly higher
than the general population [36, 40, 44].
Several studies identified additional risk factors associ-
ated with the prevalence of intestinal parasites. Not
wearing shoes, not washing hands [21, 34], not trimming
fingernails, or having dirt under the nails [34] were sta-
tistically significantly associated (P < 0.05) with intestinal
helminths (including Strongyloides). Eating unwashed/
raw fruit, open field defecation, and living in a rural area
was statistically significantly associated (P < 0.05) with
intestinal parasites (including Strongyloides and other
parasites) [31]. However, there were no statistically sig-
nificant risk factors associated with strongyloidiasis spe-
cifically. This could be a result of the small sample sizes
due to the lower prevalence of strongyloidiasis. It also
highlights the need for more systematic approaches to
epidemiological studies investigating the prevalence and
risk factors for strongyloidiasis.
Clinical manifestations
Table 2 presents studies describing clinical manifesta-
tions of strongyloidiasis in Ethiopian individuals. The
most common clinical presentation was anemia, which
was observed in immunocompetent adults and children
and HIV positive children. Immunocompromised indi-
viduals presented with a range of symptoms and clinical
manifestations including eosinophilia, fever, vomiting,
hematemesis, diarrhea, abdominal pain, bacteremia, sep-
sis, cough, respiratory distress, chronic obstructive pul-
monary disease, hypoxemia, diffuse alveolar hemorrhage
and meningitis (Table 2). Two studies reported cases of
hyperinfection, one of which was fatal [51, 52]. Another
study by Nadir & Zimhony [50] reported eight cases of
strongyloidiasis in AIDS patients, seven of which were
fatal. The diagnosis of strongyloidiasis in these cases
was complicated by negative serology results but diag-
nosis was confirmed through PCR and microscopy.
Negative serology results were also observed in two
reported cases of strongyloidiasis in immunocompe-
tent children and diagnosis was achieved through
stool examination [47, 48, 50].
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Environmental sources
There were four studies that detected S. stercoralis in
potential environmental sources. Two studies detected S.
stercoralis in dog faeces [55, 56] and two in non-biting
cyclorrhaphan flies [57, 58], all of which used micros-
copy based stool examination techniques. A study con-
ducted in Hawassa examined 448 dogs and found 31%
were positive for S. stercoralis [56]. Another examined
384 pet dogs and 46 stray dogs in Bahir Dar and
found 30% and 46% positive respectively [55]. A
study in Woreta examined 6530 non-biting cyclor-
rhaphan flies and found the overall presence of S.
stercoralis to be 1.7%. This included 12% of Chryso-
mya rufifacies, 16% Musca sorbens and 34% Lucilia
cuprina. However, Musca domestica, Calliphora
vicina, Chrysomya bezziana and Wohlfahrtia magni-
fica were all negative [58]. These findings support a
previous study conducted in Addis Ababa which ex-
amined 9550 non-biting cyclorrhaphan flies and
found that 0.1–0.2% of C. rufifacies and 0.6% of M.
sorbens were positive for S. stercoralis, whereas L.
cuprina, M. domestica, C. vicina, Sarcophaga spp.,
and Wohlfahrtia spp. were all negative. Interest-
ingly, S. stercoralis positive flies were only found in
defecating areas or garbage and were not found
near the butchery or market [57].
Discussion
This systematic review revealed that the prevalence of S.
stercoralis in HIV negative Ethiopians ranged from 0.2 to
11.1% in adults and 0.3% to 20.7% in children and the cal-
culated overall prevalence was 0.5–2.5% and 8.6% in adults
and children respectively. This is comparable with other
studies from Sierra Leone, Côte d’Ivoire and Sudan, which
found the prevalence of S. stercoralis to be less than 5%
[59–61]. However, it is lower compared with other studies
from Angola, Nigeria and Ghana, which found the inci-
dence of strongyloidiasis to be above 15% [25, 62, 63]. The
differences in prevalence observed in different studies may
be due to different laboratory techniques, study populations,
geographical factors, or economic status. In studies explor-
ing the prevalence in children a common clinical presenta-
tion identified was anemia (Table 1). This suggests that
undiagnosed strongyloidiasis in children may have signifi-
cant long term consequences as iron deficiency and anemia
in early childhood is associated with impaired cognition and
learning ability [64]. This presents an issue of significant
public health, economic and social concern for Ethiopia as
infection in children can adversely affect physical, mental,
education and overall societal development [65].
In this review, HIV positive individuals represented
the highest risk group for S. stercoralis infection in
Ethiopia. This finding supports several previous studies
conducted across the globe [66, 67]. It is interesting to
note that the increased risk of strongyloidiasis in HIV
positive individuals is not associated with an increase in-
cidence of disseminated or hyperinfection [68]. Only one
case of hyperinfection in a 36-year-old HIV positive in-
dividual was identified in this review [52]. However, a
case report of strongyloidiasis in eight AIDS patients il-
lustrated the severity of this disease in immunocom-
promised individuals with seven out of eight cases
resulting in fatalities [50]. A complication of strongyloid-
iasis in HIV positive and immunocompromised individ-
uals is the observation that serology can be falsely
negative [50, 69]. Previous global studies have also iden-
tified human T-cell lymphotropic virus type 1 Infection
(HTLV-1) and alcoholism as risk factors for strongyloid-
iasis [70]; however, this was not seen in the Ethiopian
studies. Although the absence of these risk factors could
be attributed to a lack of a systematic approach to epi-
demiological surveillance of strongyloidiasis in Ethiopia.
There was a significant discrepancy in the prevalence
observed in Ethiopia based on the diagnostic methods
used in a study. Comparisons between studies found that
the microscopy based techniques could potentially
underestimate the prevalence by four fold compared
with serology or PCR. As the majority of studies identi-
fied in this review used microscopy based techniques the
true incidence of strongyloidiasis could be much higher.
This supports a recent study that suggests that S. stercoralis
infection could be overlooked and neglected in Ethiopia
[27]. Similarly, a review of the global perspectives of stron-
gyloidiasis indicated that the disease was currently underes-
timated in many countries, but despite this underestimation,
prevalence is steadily increasing [71].
In Ethiopia, a higher prevalence of S. stercoralis was re-
corded in farmers and in rural populations. These findings
are supported by studies conducted in Cambodia and
China which identified rural populations to be at greater
risk for strongyloidiasis [72, 73]. This could be due to
greater environmental contamination by the larvae of S.
stercoralis and conditions supporting their survival. How-
ever, there is a need for environmental sampling to confirm
this assumption and to identify the main environmental
reservoirs. Global studies have also indicated that tropical
and subtropical settings in areas of economic disadvantage
provide ideal conditions for transmission dynamics of S.
stercoralis [71, 74]. This highlights the needs for research
identifying the best practice in managing these environ-
mental systems to break the life cycle and transmission dy-
namics of this parasite.
There were several studies which demonstrated the in-
cidence of strongyloidiasis in Ethiopian food handlers
was not greater than that of the general public. This sup-
ports the findings of a study in Malaysia which detected
S. stercoralis in water samples that were used in the pro-
duction of different vegetables (pegaga, kesum and water
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spinach) suggesting that vegetables and herbs may be a
source of strongyloidiasis in this region [75].
Two studies demonstrated the prevalence of S. stercor-
alis in Ethiopian dogs [55, 56]. This is noteworthy given
recent studies that have demonstrated the potential zoo-
notic transmission of S. stercoralis from dogs to humans
[76, 77]. This incidence of S. stercoralis in Ethiopian
dogs should inform future strategies for the control of
strongyloidiasis. This is particularly relevant to the argu-
ment that mass drug administration schemes to treat
human should consider concomitant treatment of dogs
[78]. The two studies that detected S. stercoralis in non-
biting cyclorrhaphan flies [57, 58] provide further insight
into the potential transmission and environmental reser-
voirs of this parasite. This association with flies found in
defecating areas and garbage supports the argument that
strongyloidiasis is associated with improper sanitation
hardware [74] although there is a need for further re-
search to explore survival and transmission from these
sources. It is also significant when considering the argu-
ment made by Gove [79] almost thirty years ago that the
most effective approach to controlling Strongyloides in-
fection is to control the environmental sources.
The complied information on clinical manifestations
suggests that strongyloidiasis commonly presents with
anemia, diarrhea, vomiting and eosinophilia. It provides a
body of evidence for control campaigns or clinical manage-
ment schemes to critically consider high-risk groups, such
as HIV positive children, who may benefit from routine
testing and/or de-worming of helminth infection [80]. Cur-
rently there are no government programs specifically target-
ing the surveillance, treatment and intervention of
strongyloidiasis in Ethiopia. However, the Federal Ministries
of Health and Education in collaboration with different
international organizations deliver deworming treatments
to children to tackle soil-transmitted helminthiases (intes-
tinal worms) and schistosomiasis (bilharzia). These treat-
ments programs are being scaled up each year and have the
target of reaching 26.1 million children annually (80% of all
at-risk children) by 2020 [81]. However, to be able to evalu-
ate the effectiveness of these deworming programs there is
a need for a systematic approach using a combination of
molecular and serology based diagnostic to ascertain the
true incidence and burden of strongyloidiasis. Currently
there is not enough information to inform medical practi-
tioners and public health policy advisors. For example,
there are limited reports from the Eastern and South
Western parts of Ethiopia, although there are many
hospital-based studies were reported from northern
and southern part of the country which were mainly
conducted by universities in the nearby areas. In
addition to this, there are very few reports investigat-
ing the role of domestic animals and environmental
reservoirs in the transmission of this disease.
Conclusions
This review identified that strongyloidiasis is a potentially
overlooked and neglected disease in Ethiopia. Currently,
there is limited information on the epidemiological situ-
ation of strongyloidiasis across the country and the studies
that are available are based on microscopy techniques that
underestimate the true incidence. The incidence of stron-
gyloidiasis in children presents a significant issue for
Ethiopia as infection is associated with impaired mental
and cognitive development, affecting the education and
societal development of an individual. In order to break
the cycle of disease transmission future research is needed
to identify the environmental reservoirs and routes of ex-
posure. This includes the potential zoonotic capacity of
Strongyloides from dogs and cats and information about
survival within different reservoirs.
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